315 related articles for article (PubMed ID: 2180978)
1. Increased aggressiveness of thyroid cancer in patients with Graves' disease.
Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R
J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.
Kim WB; Han SM; Kim TY; Nam-Goong IS; Gong G; Lee HK; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2004 Jun; 60(6):719-25. PubMed ID: 15163336
[TBL] [Abstract][Full Text] [Related]
3. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
[TBL] [Abstract][Full Text] [Related]
4. Outcome of differentiated thyroid cancer in Graves' patients.
Pellegriti G; Belfiore A; Giuffrida D; Lupo L; Vigneri R
J Clin Endocrinol Metab; 1998 Aug; 83(8):2805-9. PubMed ID: 9709951
[TBL] [Abstract][Full Text] [Related]
5. [Thyroid nodules associated with Graves' disease: another argument for surgical treatment].
Kraimps JL; Bouin-Pineau MH; Maréchaud R; Barbier J
Chirurgie; 1997; 122(8-9):488-90. PubMed ID: 9616893
[TBL] [Abstract][Full Text] [Related]
6. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Jul; 8(7):571-6. PubMed ID: 9709909
[TBL] [Abstract][Full Text] [Related]
7. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Aug; 8(8):647-52. PubMed ID: 9737358
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer yield in patients with Graves' disease.
Stocker DJ; Burch HB
Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
[TBL] [Abstract][Full Text] [Related]
10. Thyroid nodules and thyroid cancer in Graves' disease.
Tam AA; Kaya C; Kılıç FB; Ersoy R; Çakır B
Arq Bras Endocrinol Metabol; 2014 Dec; 58(9):933-8. PubMed ID: 25627049
[TBL] [Abstract][Full Text] [Related]
11. Multicentre study of thyroid nodules in patients with Graves' disease.
Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J
Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060
[TBL] [Abstract][Full Text] [Related]
12. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.
Cappelli C; Braga M; De Martino E; Castellano M; Gandossi E; Agosti B; Cumetti D; Pirola I; Mattanza C; Cherubini L; Rosei EA
Surg Today; 2006; 36(2):125-30. PubMed ID: 16440157
[TBL] [Abstract][Full Text] [Related]
13. Recent outcome of Graves' disease patients with papillary thyroid cancer.
Yano Y; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K; Ito K
Eur J Endocrinol; 2007 Sep; 157(3):325-9. PubMed ID: 17766715
[TBL] [Abstract][Full Text] [Related]
14. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
[TBL] [Abstract][Full Text] [Related]
15. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
16. Thyroid carcinoma in Graves' disease.
Ozaki O; Ito K; Kobayashi K; Toshima K; Iwasaki H; Yashiro T
World J Surg; 1990; 14(3):437-40; discussion 440-1. PubMed ID: 2368449
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of thyroid cancer in patients with Graves' disease.
Ren M; Wu MC; Shang CZ; Wang XY; Zhang JL; Cheng H; Xu MT; Yan L
World J Surg; 2014 Jan; 38(1):80-7. PubMed ID: 24166025
[TBL] [Abstract][Full Text] [Related]
19. Thyroid-stimulating antibodies in patients with autoimmune disorders.
Strakosch CR; Joyner D; Wall JR
J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
[TBL] [Abstract][Full Text] [Related]
20. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
Mishra A; Mishra SK
J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
